$503 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 24 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMRN | AMARIN CORP PLCspons adr new | $25,276,000 | +14.6% | 6,303,307 | 0.0% | 5.02% | +38.8% | |
| VRML | VERMILLION INC | $18,963,000 | +7.2% | 9,825,289 | 0.0% | 3.77% | +29.9% | |
| XON | INTREXON CORP | $2,246,000 | -39.4% | 195,000 | 0.0% | 0.45% | -26.6% | |
| BIIB | BIOGEN INC | $2,029,000 | +1.8% | 6,368 | 0.0% | 0.40% | +23.2% | |
| EYES | SECOND SIGHT MED PRODS INC | $97,000 | +59.0% | 50,804 | 0.0% | 0.02% | +90.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| PACIFIC BIOSCIENCES CALIF IN | 45 | Q2 2024 | 22.6% |
| BIOGEN INC | 45 | Q2 2024 | 0.6% |
| OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
| QUIDEL CORP | 36 | Q1 2022 | 52.5% |
| AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
| VERMILLION INC | 28 | Q1 2020 | 3.8% |
| AGENUS INC | 27 | Q1 2024 | 9.8% |
| TESARO INC | 23 | Q4 2018 | 27.8% |
| ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
| MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.